InsidersTradesSigma
Track the APRICUS BIOSCIENCES, INC. stock price and the full insider trade history of the company, a publicly traded company based in United States. Shares are quoted on the US market, under the authority of SEC (Form 4). Market capitalisation: €2.2bn. The latest transaction was reported on 14 January 2016 (Acquisition). Among the most active insiders: DENNER ALEXANDER J. Every trade is accessible without an account.
Analysts rate APRICUS BIOSCIENCES, INC. Strong Buy (bullish), based on 12 analysts. Average price target: US$59.30.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
APRICUS BIOSCIENCES, INC. es una empresa de biotecnología centrada en el desarrollo de tratamientos innovadores para afecciones médicas específicas. Cotiza en NASDAQ bajo el símbolo APRI.